Literature DB >> 16514749

Human-nonhuman chimeras: a regulatory proposal on the blurring of species lines.

Nicole E Kopinksi.   

Abstract

The chimera of modern biotechnology is defined broadly as a single organism composed of a mixture of materials from two or more organisms possessing distinct genetic backgrounds. Unlike the United States, which does not regulate chimeras directly, Canada has responded to the unregulated pursuit of chimera technology by banning certain chimeras as part of comprehensive legislation designed to regulate human reproductive technologies. In 2004, the Canadian Parliament passed the Assisted Human Reproduction Act despite criticism urging greater legislative justification for the Act's provisions and modification to it statutory definitions. Because current regulatory mechanisms in the United States, including patent law and administrative oversight, fail to regulate chimera technology, the United States should enact new legislation, using Canada's legislation as a model, to prohibit embryonic chimeras and to regulate other human-nonhuman combinations. Unregulated biotechnology threatens to disrupt legal and social institutions; therefore, the United States must make a balanced effort now to protect the public interest.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach; Patent and Trademark Office; President's Council on Bioethics

Mesh:

Year:  2004        PMID: 16514749

Source DB:  PubMed          Journal:  Boston Coll Law Rev        ISSN: 0161-6587


  2 in total

1.  The gap between law and ethics in human embryonic stem cell research: overcoming the effect of U.S. federal policy on research advances and public benefit.

Authors:  Patrick L Taylor
Journal:  Sci Eng Ethics       Date:  2005-10       Impact factor: 3.525

2.  Regulatory and intellectual property conundrums surrounding xenotransplantation.

Authors:  Koko Kwisda; Tobias Cantz; Nils Hoppe
Journal:  Nat Biotechnol       Date:  2021-07       Impact factor: 54.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.